1. accedaCRIS
  2. Publicaciones
  3. Artículos
Identificador persistente para citar o vincular este elemento: http://hdl.handle.net/10553/52564
Campo DC Valoridioma
dc.contributor.authorArenas, Meritxellen_US
dc.contributor.authorSabater, Sebastiàen_US
dc.contributor.authorLara Jiménez, Pedro Carlosen_US
dc.contributor.authorRovirosa, Àngelsen_US
dc.contributor.authorBiete, Alberten_US
dc.contributor.authorLinares, Victoriaen_US
dc.contributor.authorBelles, Montseen_US
dc.contributor.authorPanés, Juliàen_US
dc.date.accessioned2018-11-30T13:12:48Z-
dc.date.available2018-11-30T13:12:48Z-
dc.date.issued2016en_US
dc.identifier.issn1507-1367en_US
dc.identifier.urihttp://hdl.handle.net/10553/52564-
dc.description.abstractImmunomodulatory effects of low-dose radiotherapy (LD-RT) have been used for the treatment of several benign diseases, including arthrodegenerative and inflammatory pathologies. Graves' disease is an autoimmune disease and radiotherapy (RT) is a therapeutic option for ocular complications. The dose recommended in the clinical practice is 20 Gy (2 Gy/day). We hypothesized that lower doses (<10 Gy total dose, <1 Gy/day) could results in higher efficacy if we achieved anti-inflammatory and immunomodulatory effects of LD-RT.We review current evidence on the effects of RT in the treatment of Graves' disease and the possible use of LD-RT treatment strategy.en_US
dc.languageengen_US
dc.relation.ispartofReports of Practical Oncology and Radiotherapyen_US
dc.sourceReports of Practical Oncology and Radiotherapy [ISSN 1507-1367], v. 21 (3), p. 213-218en_US
dc.subject32 Ciencias médicasen_US
dc.subject.otherGraves' ophthalmopathyen_US
dc.subject.otherLow-dose radiotherapyen_US
dc.subject.otherRadiotherapy for benign diseaseen_US
dc.titleRadiotherapy for Graves' disease. The possible role of low-dose radiotherapyen_US
dc.typeinfo:eu-repo/semantics/reviewes
dc.typeArticlees
dc.identifier.doi10.1016/j.rpor.2016.02.001-
dc.identifier.scopus84959534962-
dc.identifier.isi000408481700012-
dc.contributor.authorscopusid14420842300-
dc.contributor.authorscopusid14071858400-
dc.contributor.authorscopusid57150335400-
dc.contributor.authorscopusid7003472489-
dc.contributor.authorscopusid16745153100-
dc.contributor.authorscopusid8948046600-
dc.contributor.authorscopusid6603464625-
dc.contributor.authorscopusid57207594879-
dc.description.lastpage218-
dc.identifier.issue3-
dc.description.firstpage213-
dc.relation.volume21-
dc.investigacionCiencias de la Saluden_US
dc.type2Reseñaen_US
dc.contributor.daisngid305806-
dc.contributor.daisngid1010621-
dc.contributor.daisngid5799823-
dc.contributor.daisngid2426514-
dc.contributor.daisngid346684-
dc.contributor.daisngid1145927-
dc.contributor.daisngid825429-
dc.contributor.daisngid8649485-
dc.contributor.wosstandardWOS:Arenas, M-
dc.contributor.wosstandardWOS:Sabater, S-
dc.contributor.wosstandardWOS:Jimenez, PL-
dc.contributor.wosstandardWOS:Rovirosa, A-
dc.contributor.wosstandardWOS:Biete, A-
dc.contributor.wosstandardWOS:Linares, V-
dc.contributor.wosstandardWOS:Belles, M-
dc.contributor.wosstandardWOS:Panes, J-
dc.date.coverdateMayo 2016-
dc.identifier.ulpgcSíes
dc.description.sjr0,412
dc.description.sjrqQ2
dc.description.esciESCI
item.grantfulltextnone-
item.fulltextSin texto completo-
crisitem.author.fullNameLara Jiménez, Pedro Carlos-
Colección:Reseña
Vista resumida

Citas SCOPUSTM   

4
actualizado el 30-mar-2025

Citas de WEB OF SCIENCETM
Citations

4
actualizado el 30-mar-2025

Visitas

105
actualizado el 02-nov-2024

Google ScholarTM

Verifica

Altmetric


Comparte


Exporta metadatos


Los elementos en ULPGC accedaCRIS están protegidos por derechos de autor con todos los derechos reservados, a menos que se indique lo contrario.